We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Relationship Between Specific RET Proto-oncogene Mutations and Disease Phenotype in Multiple Endocrine Neoplasia Type 2 International RET Mutation Consortium Analysis

Charis Eng, MD, PhD; David Clayton; Isabelle Schuffenecker, PhD; Gilbert Lenoir, DVM, PhD; Gilbert Cote, PhD; Robert F. Gagel, MD; Hans Kristian Ploos van Amstel, PhD; Cornelis J. M. Lips, MD, PhD; Isamu Nishisho, MD; Shin-Ichiro Takai, MD; Debbie J. Marsh, PhD; Bruce G. Robinson, MD; Karin Frank-Raue, MD; Friedhelm Raue, MD; Feiyu Xue, PhD; Walter W. Noll, MD; Cristina Romei, PhD; Furio Pacini, MD; Monika Fink, PhD; Bruno Niederle, MD; Jan Zedenius, MD, PhD; Magnus Nordenskjöld, MD, PhD; Paul Komminoth, MD; Geoffrey N. Hendy, PhD; Hossein Gharib, MD; Stephen N. Thibodeau, PhD; André Lacroix, MD; Andrea Frilling, MD; Bruce A. J. Ponder, MB, PhD, FRCP; Lois M. Mulligan, PhD
JAMA. 1996;276(19):1575-1579. doi:10.1001/jama.1996.03540190047028.
Text Size: A A A
Published online


Objective.  —Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant disorder. The 3 recognized subtypes include MEN 2A, characterized by medullary thyroid carcinoma (MTC), pheochromocytoma (pheo), and hyperparathyroidism (HPT); MEN 2B, by MTC, pheo, and characteristic stigmata; and familial MTC (FMTC), by the presence of MTC only. The purpose of this study was to establish the relationship between specific mutations and the presence of certain disease features in MEN 2 which could help in clinical decision making.

Design.  —Correlative survey study of 477 MEN 2 families.

Setting.  —Eighteen tertiary referral centers worldwide.

Patients.  —A total of 477 independent MEN 2 families.

Main Outcome Measures.  —Association between the position and type of germline mutation in the RET proto-oncogene and the presence or absence of MTC, pheo, HPT, and/or other features in a family.

Results.  —There is a statistically significant association between the presence of any mutation at a specific position (codon 634) and the presence of pheo and HPT. The presence of a specific mutation, CGC at codon 634, has yet to be associated with FMTC. Conversely, mutations at codons 768 and 804 are thus far seen only with FMTC, while codon 918 mutation is MEN 2B-specific. Rare families with both MEN 2 and Hirschsprung disease were found to have MEN 2-specific codon mutations. Patients with Hirschsprung disease presenting with such mutations should be monitored for the possible development of MEN 2 tumors.

Conclusions.  —This consortium analysis suggests that genotype-phenotype correlations do exist and, if made reliably absolute, could prove useful in the future in clinical management with respect to screening, surveillance, and prophylaxis, as well as provide insight into the genetic effects of particular mutations.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.